South Africa’s health department confirmed a new case of monkeypox (Mpox) on May 9th, 2024, in a 35-year-old Gauteng resident with no recent travel history. This case highlights the ongoing global threat of Mpox and the emergence of a potentially more transmissible variant.
Mpox is a viral infection that causes flu-like symptoms and a rash. While most cases resolve within weeks, some can become severe. This case is concerning because it involves the clade I variant of the monkeypox virus, known for its higher virulence compared to the globally circulating clade II.
“The National and Gauteng Departments of Health are actively managing the situation,” the department said, including contact tracing to identify any linked cases.
Additionally, a new, highly transmissible variant called “clade 1b” emerged in the Democratic Republic of Congo (DRC) in April 2024. This raises concerns about a potential pandemic, as transmission appears to be primarily sexual, particularly among female sex workers.
Health officials urge vigilance as Mpox can spread through close contact with an infected person or contaminated materials. Isolation of confirmed cases is crucial to prevent further transmission. While the risk to the general population is considered low, healthcare professionals are advised to be on the lookout for potential cases.
This is the first Mpox case reported in South Africa since August 2022. The World Health Organization (WHO) recommends increased vigilance for cases and monitoring of confirmed infections. Mass vaccination is not currently advised.
Leave a comment